Taiwan FDA registration 7a126e8f2e2716c8d3a05f11176c3ab2

Philips neonatal bilirubin (total and unbound) test system (unsterilized)

TW: “飛利浦”新生兒膽紅素(總量及未結合的)試驗系統(未滅菌)

Taiwan·Risk Class 1·PHILIPS MEDICAL SYSTEMS·Registered Aug 11, 2010 – Aug 11, 2025Expired

Registration details

Analysis ID: 7a126e8f2e2716c8d3a05f11176c3ab2
Customs Code: DHA04400907402

Company information

Manufacturer: PHILIPS MEDICAL SYSTEMS
Manufacturer Country: United States
Authorized Representative: PHILIPS TAIWAN LIMITED

Product details

Intended Use: It is limited to the first level of identification scope of the "Neonatal Bilirubin (Total and Unbound) Test System (A.1113)" of the Measures for the Classification and Grading of Medical Devices.
Product Type (Level 1): A Clinical chemistry and clinical toxicology
Product Type (Level 2): A.1113 Neonatal bilirubin (total and unconjugated) test system
Import Information: import

Dates and status

Registration Date: Aug 11, 2010
Expiry Date: Aug 11, 2025

About this record

Access comprehensive regulatory information for Philips neonatal bilirubin (total and unbound) test system (unsterilized) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number 7a126e8f2e2716c8d3a05f11176c3ab2 and manufactured by PHILIPS MEDICAL SYSTEMS. The authorized representative in Taiwan is PHILIPS TAIWAN LIMITED.

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.